Impact of COVID-19 lockdown on glycaemic control in young people with type 1 diabetes: a retrospective review at a large hospital by Lawrence, N. et al.
This is a repository copy of Impact of COVID-19 lockdown on glycaemic control in young 
people with type 1 diabetes: a retrospective review at a large hospital.




Lawrence, N. orcid.org/0000-0002-7686-6172, Natarajan, A., Petkar, R. et al. (1 more 
author) (2020) Impact of COVID-19 lockdown on glycaemic control in young people with 
type 1 diabetes: a retrospective review at a large hospital. Diabetes Care for Children & 
Young People, 10 (2). ISSN 2050-1528 





Items deposited in White Rose Research Online are protected by copyright, with all rights reserved unless 
indicated otherwise. They may be downloaded and/or printed for private study, or other acts as permitted by 
national copyright laws. The publisher or other rights holders may allow further reproduction and re-use of 
the full text version. This is indicated by the licence information on the White Rose Research Online record 
for the item. 
Takedown 
If you consider content in White Rose Research Online to be in breach of UK law, please notify us by 
emailing eprints@whiterose.ac.uk including the URL of the record and the reason for the withdrawal request. 
Diabetes Care for Children & Young People Volume 10 No 2 2021 1
Article
Impact of COVID-19 lockdown on glycaemic 
control in young people with type 1 diabetes:  
a retrospective review at a large hospital
Neil Lawrence, Anuja Natarajan, Razia Petkar, Lovlin Joseph
Citation: Lawrence N, Natarajan A, 
Petkar R, Joseph L (2021) Impact of 
COVID-19 lockdown on glycaemic 
control in young people with 
type 1 diabetes: a retrospective 
review at a large hospital. Diabetes 
Care for Children & Young People 
10: [early view publication]
Article points
1. Glycaemic control (HbA
1c
 
and glucose time-in-range) 
improved in children and 
adolescents in Doncaster 
and Bassetlaw in the 12 
weeks following national 
lockdown despite reduced 
face-to-face consultations.
2. COVID-19 lockdown has 
demonstrated the difficulties 
in managing type 1 diabetes 
outside the home.
3. Increased education on 
managing type 1 diabetes 
around changes in routine, 
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This study aimed to determine whether the UK lockdown to reduce COVID-19 
transmission had an impact on glycaemic control in children and adolescents with 
type 1 diabetes. Data from the continuous and intermittent glucose monitoring 
devices of patients at Doncaster and Bassetlaw Teaching Hospitals were compared 
alongside changes in patient contact in the 12 weeks prior to and following lockdown. 
Excluding newly-diagnosed patients (within 1 year), HbA
1c
 levels decreased from 
67.4 mmol/mol to 61.3 mmol/mol (8.3% to 7.8%; p<0.001) and mean glucose from 
9.7 mmol/L to 9.5 mmol/L (p=0.034), with smaller standard deviation (4.4 mmol/L 
versus 4.2 mmol/L, p<0.001) after lockdown. Time-in-range (3.9–10.0 mmol/L) 
increased from 55.2% to 58.0% (p=0.017), with no change in time below range 
(4.8% versus 5.0%, p=0.495). Glycaemic control improved in the 12 weeks following 
national lockdown. These findings suggest that increased remote contact with patients 
with type 1 diabetes has not been detrimental to glycaemic control.
S
evere acute respiratory syndrome coronavirus 
2 (COVID-19) caused the global pandemic 
that resulted in a national lockdown from 23 
March 2020 (Dropkin, 2020). During lockdown, 
the way young people with type 1 diabetes (T1D) 
were monitored and supported changed from 
predominantly face-to-face consultations to 
remote contact. School and college closures along 
with restricted activity outside the home changed 
patients’ routines. Lockdown measures began 
to be eased from 10 May 2020. While the full 
national lockdown was 6 weeks in total duration, 
the majority of school children throughout the 
country did not attend school in May and June and 
outpatient services were still significantly restricted. 
The impact of lockdown on young people’s diabetes 
management was unknown, therefore glycaemic 
control (HbA
1c
 and glucose levels) before and after 
lockdown was compared to assess the impact on this 
patient cohort. 
Method
Data from individual glucose monitoring devices 
were collected across a 12-week period from 30 
December 2019 to 22 March 2020 and compared to 
data captured between 30 March 2020 and 21 June 
2020. HbA
1c
 results from the same period before 
lockdown were compared to any HbA
1c
 result taken 
after 23 June 2020 and before 13 August 2020. This 
avoided the inclusion of HbA
1c
 results that reflected 
glycaemic control spanning both the pre- and post-
lockdown period. 
All patients at Doncaster and Bassetlaw Teaching 
Hospitals NHS Foundation Trust with T1D who 
were under the care of a paediatric diabetologist 
were assessed for inclusion in the data analysis. 
Patients used continuous glucose monitoring 
(CGM), a flash glucose system (FGS) or self-
monitoring of blood glucose (SMBG) to measure 
glucose levels. The CGM device used was the 
Dexcom G6 (Dexcom, Inc., San Diego, CA), which 
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has Bluetooth-enabled connectivity and is able to 
transfer data in real time to a patient’s smartphone 
and in turn to cloud storage (Dexcom, 2017). 
The FGS used was the FreeStyle Libre (Abbott 
Diabetes Care, Alameda, CA), which holds 8 hours 
of glucose readings and requires the patient to 
scan a smartphone or associated handheld device 
by holding it 4 cm from the sensor to retrieve the 
most recent data (Abbott, 2017). Data on CGM- 
and FGS-measured glucose levels were collected 
via the online Dexcom (Dexcom, 2017) and 
Libreview (Abbott, 2017) platforms, respectively. 
The remaining patients assessed were performing 
SMBG alongside diasend blood glucose monitoring 
software system (Glooko, Gothenberg, Sweden), 
which allows patients to upload their data at home 
and for these data to be remotely accessed by the 
diabetes team (diasend, 2020). 
Patients were included in analysis if, in both the 
pre- and post-lockdown periods, data from ≥70% of 
total possible CGM or FGS readings or from >3.5 
(>70%) SMBG readings per day were available. 
Patients conducting SMBG are advised to test their 
blood sugar at least five times a day as per national 
guidance (NICE, 2016), 
Due to the alteration and temporary improvement 
in glycaemic control that can be experienced in the 
‘honeymoon period’ soon after diagnosis (Abdul-
Rasoul et al, 2006), patients with a diagnosis of 
T1D in the 12 months prior to 30 December 2019 
were excluded from analysis. Patients diagnosed 
with T1D during the lockdown period were also 
excluded.
The mode of patient contact by paediatric 
diabetes specialist nurses (PDSNs) was logged in 
the electronic patient record. This information was 
accessed after the study period to determine the 
total number of face-to-face and telephone contacts 
before and after lockdown.
The primary outcome measures were HbA
1c
 
and mean glucose level. Secondary outcome 
measures were standard deviation in glucose levels 
and proportion of time spent within target range 
(for those using CGM or FGS). Target range 
was a glucose level of between 3.9 mmol/L and 
10 mmol/L, as defined by international consensus 
(Danne et al, 2017). Glucose levels were recorded 
every 5 minutes by CGM and every 15 minutes by 
FGS. To accommodate short periods with missing 
glucose values, eg due to a sensor change or signal 
loss, time-in-range was considered continuous 
provided data points were ≤2 hours apart. For data 
>2 hours apart, the time frame was considered 
missing data and discounted. 
Statistical analysis
Analysis was conducted using R (R Foundation for 
Statistical Computing, Vienna, Austria, www.R-
project.org). The histograms and quantile–quantile 
plots of the data being compared were assessed 
and found to have normal distributions, which 
justified the use of parametric testing. Comparisons 
before and after lockdown were conducted using 
student’s paired t-test and comparisons between 
the three groups were conducted with analysis of 
variance (ANOVA). Comparison of categorical 
data exploring the method of patient contact was 
conducted using chi-squared test. The threshold for 
statistical significance was set at p<0.05.
Results
Demographics
The records of total of 82 (42 male and 40 female) 
patients from Bassetlaw District General Hospital 
and 182 (93 male and 89 female) patients from 
Doncaster Royal Infirmary with T1D were 
reviewed. Forty-four were excluded as they had 
been diagnosed after 30 December 2018 and were 
therefore considered to be within their ‘honeymoon 
period’. Of the remaining patients, 122 had paired 
HbA
1c 
readings taken in both pre- and post-
lockdown periods. These patients had a median age 
of 14.2 years (interquartile range [IQR]=5.1). There 
were 47 patients beyond their honeymoon period 
using CGM or FGS and 33 using SMBG with 
sufficient data available for analysis, giving a total of 
80 patients for full analysis (median age 13.6 years, 
IQR=5.9). Patient demographics and parameters of 
glycaemic control are given in Table 1. 
The average age of patients in the CGM, FGS 
and SMBG groups differed significantly (p<0.001), 
making comparison between devices inappropriate. 
There was no between-group difference in time 
since T1D diagnosis (p>0.05). While in-depth 
information about intercurrent illnesses during this 
period was not available, none of the patients in 
the analysis required hospital admission during the 
study period.
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Monitoring method Continuous glucose monitoring, 
Dexcom G6
Flash glucose monitoring,  
FreeStyle Libre
Self-monitoring of blood 
glucose#
Total/average
Number of patients 39 76 56 264
Number included in analysis† 23 24 33 80
Median age, years (interquartile range) 9.6 (5.2) 13.8 (5.4) 14.5 (3.5) 13.6 (5.9)
Pre LD Post LD P-value Pre LD Post LD P-value Pre LD Post LD P-value Pre LD Post LD P-value
Mean glucose level (SD), mmol/L 9.4 (1.1) 9.1 (1.0) 0.073 9.9 (1.2) 9.5 (1.2) 0.088 9.9 (2.0) 9.7 (1.7) 0.544 9.7 (1.6) 9.5 (1.4) 0.044*
Mean standard deviation of glucose 
(SD), mmol/L
3.8 (0.8) 3.6 (0.8) 0.002* 4.4 (0.9) 4.2 (0.8) 0.123 4.8 (1.3) 4.5 (1.1) 0.008* 4.4 (1.1) 4.1 (1.0) <0.001*

















 reading before lockdown,§ n 21 24 27 180
HbA
1c
 reading after lockdown,§ n 15 17 24 137
Paired HbA
1c
 readings,§ n 14 17 19 122
Mean HbA
1c 
(SD),§ mmol/mol 57.6 (6.6) 54.2 (10.2) 0.301 62.9 (6.7) 55.8 (13.5) 0.025* 64.1 (14.3) 57.4 (10.5) 0.040* 67.4 (17.6) 61.3 (14.09) <0.001*
*Significant difference; #patients that intermittently check blood glucose by glucometer and upload to diasend but do not use continuous or flash glucose monitoring; †excluding 
patients diagnosed after 30 December 2018 (honeymoon period) and patients with <70% glucose readings available; ‡target range: 3.9–10.0 mmol/L (SMBG readings too far apart 
to accurately calculate time-in-range); §excluding patients diagnosed after 30 December 2018; SD = standard deviation 
Table 1. Glycaemic control before lockdown (pre LD) and after lockdown (post LD)
Impact of COVID-19 lockdown on glycaemic control in young people with type 1 diabetes 
4 Diabetes Care for Children & Young People Volume 10 No 2 2021
Consultation format
The PDSNs recorded 245 face-to-face consultations 
before lockdown and 151 afterwards, representing 
a 39% decrease in the number of meetings held in 
person. There was a corresponding 30% increase in 
the number of telephone consultations, from 1751 




 levels significantly decreased from 
67.4 mmol/mol (8.3%) to 61.3 mmol/mol (7.8%) 
across the total cohort (n=122), see Figure 1. 
The reduction was significant in the 50 
patients with adequate glucose monitoring data 
(60.9 mmol/mol [7.7%] versus 56.4 mmol/mol 
[7.3%], p=0.003). Significant HbA
1c 
reductions 
in paired readings were recorded for the 17 
patients using FGS (62.9 mmol/mol [7.9%] versus 
55.8 mmol/mol [7.3%], p=0.025) and 19 patients 
using SMBG (64.1 mmol/mol [8.0%] versus 
57.4 mmol/mol [7.4%], p=0.040), however the 
reduction in the 14 patients using CGM did not 
reach significance (57.6 mmol/mol [7.4%] versus 
54.2 mmol/mol [7.1%], p>0.05). 
Analysis of uploaded data from all 80 glucose 
monitoring devices revealed a lower mean glucose 
after lockdown (9.7 mmol/L versus 9.5 mmol/L, 
p=0.034), see Figure 2. Glucose variability, as 
measured by the standard deviation of glucose 
readings, decreased significantly from 4.4 mmol/L 
to 4.1 mmol/L (p<0.001), see Figure 3. Glucose 
time-in-range increased (p=0.017), with time above 
range decreasing at a level close to significance 
(p=0.055) and time below range remaining the same 
(p=0.495), see Figure 4. The mean and standard 
deviations for these comparisons are given in Table 1.
Discussion
This study shows an improvement in glycaemic 
control in children and adolescents with T1D after 
national lockdown and the closure of schools in 
the UK due to the COVID-19 global pandemic. 
HbA
1c
 and mean glucose improved, with glucose 
monitoring data showing that this was a result of 
greater time spent within target glucose range, with 
no increase in time spent below range. The standard 
deviation of glucose levels decreased, showing less 
variability following lockdown.
Figure 1. Comparison of HbA
1c
 before and after lockdown
CGM = continuous glucose monitors; FGS = flash glucose system; SMBG = self-monitoring of blood glucose. Total cohort includes all patients across the hospital trust who 
had an HbA
1c
 reading taken in both the pre- and post-lockdown, including some patients who did not upload sufficient glucose monitoring data for analysis in either period
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After lockdown was announced, in line with 
UK national recommendations (Stevens, 2020), 
non-urgent face-to-face consultations within the 
hospital trust were cancelled. Consultant clinics were 
changed to virtual appointments after 23 March 
2020, with few exceptions. In-person contact was 
gradually reintroduced in May, dependent upon 
the clinical need of individual patients, but at lower 
levels than prior to lockdown. During the lockdown, 
face-to-face contact by PDSNs – as logged in the 
electronic patient record – dropped by 39% but 
was replaced by a 30% increase in the number 
of telephone contacts. A ‘drive-by’ service was 
introduced during this period that complemented 
remote contact. This service enabled staff members 
to test patients’ HbA
1c
 or upload glucose monitoring 
data if the patients and their families did not have 
the ability to do so themselves. The diabetes team 
experienced very good engagement with remote 
contacts, likely aided by the restrictions placed on 
travel and activities throughout the country that 
resulted in families being easier to contact. PDSNs 
aimed to contact patients at least fortnightly, 
although there was flexibility in targeting patients 
with the greatest clinical need. Reduced staff travel 
time meant team members were able to provide 
broader patient support. It was observed that 
patients who previously were averse to uploading 
glucose data become more proactive in doing so 
during lockdown.
During the 2020 lockdown period glycaemic 
control improved in adults with T1D using CGM 
in Scotland, Italy and Spain (Bonora et al, 2020; 
Capaldo et al, 2020; Dover et al, 2020). However, 
a group in India who surveyed patients with T1D 
who were performing SMBG during lockdown 
found increases in average blood glucose and HbA
1c
, 
which was attributed to the reduced availability of 
blood glucose test strips (Verma et al, 2020). A study 
of 34 children in Greece showed similar glycaemic 
control in patients on insulin pump therapy before 
and after lockdown, but a significant change in their 
meal schedules (Christoforidis et al, 2020). To the 
best of the authors’ knowledge, the current study 
is the first to analyse the impact of lockdown on 
glycaemic control in children and adolescents with 
T1D in the UK.
Regular televised UK government updates 
and a strong focus in the media have resulted in 
greater health awareness during the pandemic 
CGM = continuous glucose monitors; FGS = flash glucose system; SMBG = self-monitoring of blood glucose
Figure 2. Comparison of mean glucose before and after lockdown
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(BBC, 2020). The increased risk of mortality in 
those with diabetes who contract COVID-19 may 
have crystallised the importance of glycaemic 
control within families (Huang et al, 2020). While 
circumstances will have differed across the families 
in the cohort, it is likely that most patients had more 
time to concentrate on diabetes care as a result of 
reduced school and extracurricular activities as well 
as an increased level of supervision from parents. 
While PDSNs have used telephone contact with 
patients consistently for many years, families have 
appreciated the convenience of being able to liaise 
with physicians and dietitians in the diabetes team 
over the telephone rather than having to attend face-
to-face appointments, which may have contributed 
to improved glycaemic control. 
The strengths of this study are the large patient 
cohort included and the significant amount 
of reliable data available from modern glucose 
monitoring systems. While CGM and FGS 
measure interstitial glucose, the sensor models used 
by patients at Doncaster and Bassetlaw Teaching 
Hospitals have been shown to correlate very closely 
with blood glucose, are factory calibrated and show a 
low mean absolute relative difference in independent 
testing (Welsh et al, 2019). The glucometers used by 
patients performing SMBG are linked directly to 
diasend software, removing the possibility of human 
error or bias when recording or transcribing results. 
This was a retrospective review of real-world 
local data and care should be taken before applying 
the findings to other patient populations. The 
cohort was heterogenous, as school closure was 
not universal and not all families stayed at home 
throughout this period; workers deemed essential 
to the functioning of society remained in work and 
were able to send their children to school. There are 
no data on the proportion of people in this study 
who stayed at home or to what degree they complied 
with government advice during lockdown. While 
no patients required hospital admission during this 
period, data on episodes of mild illness are lacking. 
The national lockdown was designed to reduce 
the spread of COVID-19 infection, but also likely 
reduced the spread of other infectious diseases that 
may have contributed to the observed improvement 
in glycaemic control. 
Good glycaemic control in children and 
adolescents improves short-, medium- and long-term 
health outcomes (Prince et al, 2007, Monaghan et 
CGM = continuous glucose monitors; FGS = flash glucose system; SMBG = self-monitoring of blood glucose
Figure 3. Standard deviation of glucose before and after lockdown
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al, 2015). Modern technology affords the luxury of 
maintaining good patient contact and monitoring 
blood sugar levels without the inconvenience of 
families having to travel to attend appointments. 
The data highlight that T1D is challenging to 
manage outside the home. Continued contact with 
patients and families in ways convenient for them 
is recommended to maintain engagement, as is 
focusing education on how to manage T1D around 
changes in routine, particularly school and physical 
exercise. This study reiterates the importance of 
good communication between members of the 
diabetes team, carers of those with T1D and school 
staff to achieve good glycaemic control. 
Conclusion
Glycaemic control in children and adolescents with 
T1D improved in the 12 weeks following national 
lockdown during the COVID-19 pandemic. This 
finding demonstrates the difficulties associated with 
managing T1D around school pressures, meals away 
from home, social engagements and peer pressure. It 
also highlights the importance of patient and carer 
education about managing T1D outside the home. 
Increased remote contact with patients with T1D 
has not been detrimental to glycaemic control.  n
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